Diagnostics News and Research

RSS

Study: Role of genetics and environment in autism spectrum disorders

Researchers at The University of Texas Health Science Center at Houston and the University of the West Indies have joined forces to launch a study of Jamaican children that they hope will unlock the secrets of how genetics and environment may interact to cause autism spectrum disorders.

29 Sep 2009

SAIC-Frederick and Roche collaborate on technology advancements in sequencing cancer genes

National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation, and Roche Applied Science, a division of Roche Diagnostics Corporation, have signed a collaboration agreement to assess Roche’s advanced technologies to sequence the genomes of cancer research samples.

From Roche Sequencing and Life Science 29 Sep 2009

New microchip to detect type and severity of cancer

UofT researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment.

29 Sep 2009

Biomagnetics Diagnostics to develop handheld testing platform for malaria and bovine TB

Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million from investors and an anonymous philanthropic source. These funds will be used to further develop the company’s unique handheld testing platform targeting the areas of malaria and bovine tuberculosis testing.

29 Sep 2009

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis.

28 Sep 2009

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Correlagen Diagnostics Inc., a leading provider of genetic testing for disease diagnosis, today announced the acquisition of a system from and a scientific collaboration with Helicos BioSciences Corporation.

28 Sep 2009

Austrian Institute of Technology adopts Arrayit's Microarray Platform for detecting dangerous pathogens

Arrayit Corporation, a proprietary life sciences and technology leader, disclosed that its Microarray Platform has been adopted by Austrian Institute of Technology.

28 Sep 2009

New scalable solutions for targeted re-sequencing studies from febit holding and Life Technologies

febit holding GmbH and Life Technologies Corporation today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted re-sequencing studies. In addition, febit will expand its Genomic Services Facility at Heidelberg by adding several Applied Biosystems SOLiD™ high-throughput sequencing systems and real-time PCR systems.

28 Sep 2009

UTAS chooses ADI Blackfin processors to ensure high quality patient care

Analog Devices, Inc. (NYSE: ADI) today announced that UTAS, a provider of medical devices for patient monitoring and diagnostics, has selected ADI Blackfin® processors to ensure high-performance digital signal processing operations and robust functionality across its full line of products.

28 Sep 2009

The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system.

25 Sep 2009

Neogen announces first-quarter results of fiscal 2010

Neogen Corporation announced today that its revenues for the first quarter of FY 2010, which ended Aug. 31, increased 12% from the previous year's first quarter to $32,347,000. First quarter net income increased 18% from the prior year's $3,733,000 to $4,395,000, or to $0.29 per share in the current year compared to the previous year's $0.25.

25 Sep 2009

PROSPECT clinical trial results announced

Abbott today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial.

25 Sep 2009

Collaboration for the evaluation of peptide copolymer technology

Peptimmune, Inc., a privately held biotechnology company announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC), Silver Spring, MD to evaluate the Company's proprietary DEEP(TM) peptide copolymer technology for the potential development of dengue vaccines and point-of-care diagnostics.

25 Sep 2009

Axial Biotech's SCOLISCORE AIS Prognostic Test now available in the U.S.

Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.

24 Sep 2009

Amorfix Life Sciences to present Amorfix's EP-vCJD blood screening test for vCJD at WFH Global Forum

Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, announced today that its Chief Executive Officer, Dr. George Adams, will present Amorfix's EP-vCJD(TM) blood screening test for variant Creutzfeldt-Jakob Disease ("vCJD") at the Sixth World Federation of Hemophilia ("WFH") Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders in Montreal, Quebec at 11:00 am ET on Friday, September 25, 2009.

24 Sep 2009

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

From QIAGEN Manchester Limited 24 Sep 2009

TRUEresult store brand blood glucose monitoring system more accurate than name brand products: Study

Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, today announced that a new study has shown that its TRUEresult® store brand blood glucose monitoring system is comparable to the performance of more expensive name brand systems.

24 Sep 2009

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Today, Scott Livingston, CEO and Founder of Livingston Securities (www.livingstonsecurities.com) announced the agenda for the 2nd Annual Livingston Healthcare and Life Science Stakeholders Summit.

23 Sep 2009

Vicor's PD2i heart-rate complexity metric to be tested on trauma patients in U.S. Army's C3E program

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Colonel Leopoldo Cancio of the U.S. Army Institute of Surgical Research (USAISR) identified its PD2i as a heart rate complexity metric that will be tested on trauma patients under the new Critical Combat Care Engineering (C3E) program.

23 Sep 2009

Biomagnetics, Bright Dairy enter into distribution agreement for China

Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has entered into an agreement with Bright Dairy, which is the third largest dairy products producer and marketer in China.

23 Sep 2009

Diagnostics News and Research

Study: Role of genetics and environment in autism spectrum disorders

SAIC-Frederick and Roche collaborate on technology advancements in sequencing cancer genes

New microchip to detect type and severity of cancer

Biomagnetics Diagnostics to develop handheld testing platform for malaria and bovine TB

Correlagen Diagnostics to develop diagnostic tests on the Helicos Genetic Analysis Platform

Correlagen to use Helicos Genetic Analysis System for diagnosing genetic disorders

Austrian Institute of Technology adopts Arrayit's Microarray Platform for detecting dangerous pathogens

New scalable solutions for targeted re-sequencing studies from febit holding and Life Technologies

UTAS chooses ADI Blackfin processors to ensure high quality patient care

The Adiana permanent contraception system supported by UK's NICE

Neogen announces first-quarter results of fiscal 2010

PROSPECT clinical trial results announced

Collaboration for the evaluation of peptide copolymer technology

Axial Biotech's SCOLISCORE AIS Prognostic Test now available in the U.S.

Amorfix Life Sciences to present Amorfix's EP-vCJD blood screening test for vCJD at WFH Global Forum

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

TRUEresult store brand blood glucose monitoring system more accurate than name brand products: Study

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Vicor's PD2i heart-rate complexity metric to be tested on trauma patients in U.S. Army's C3E program

Biomagnetics, Bright Dairy enter into distribution agreement for China

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News